Lv43
500 积分 2025-01-06 加入
Efbemalenograstim Alfa: First Approval
25天前
已完结
Comparison of a dual inhibitor of VEGF and FGF signaling, BMS-582664, to the activity of bevacizumab, an inhibitor exclusively of VEGF signaling, in xenograft models of colon carcinoma
29天前
已关闭
Diagnosis and Treatment of Metastatic Colorectal Cancer
29天前
已完结
Efbemalenograstim Alfa: First Approval
1个月前
已完结
Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
1个月前
已完结
Metabolism and Distribution of Novel Tumor Targeting Drugs In Vivo
1个月前
已完结
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated by Gemcitabine-based Chemotherapy
1个月前
已完结
Small molecules for Kirsten rat sarcoma viral oncogene homolog mutant cancers: Past, present, and future
1个月前
已完结
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study
1个月前
已完结
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
